NCT01659177 - A Study of LY2140023 in Healthy Participants | Biotech Hunter

Timeline

Start Date

August 31, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions

Healthy Participants

Interventions

DRUG

LY2140023

Administered orally

Trial Locations (1)

CH-4123

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Allschwil